← Leaderboards
Robert Olmsted
Alphavax Human Vaccines, Inc.
$7,887,006
Attributed
$7,887,006
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.5M · FY2005–09$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$7,887,006 · 2
By mechanism
UC1$6,490,848 · 1
U01$1,396,158 · 1
Top collaborators
No co-investigators on record.
Most similar at Alphavax Human Vaccines, Inc.
Same institution · by research overlap
- Jonathan Smith$21,963,803
- Kurt I Kamrud$3,800,000
- Robert A Olmsted$500,000
Others in their field
Top investigators on “Adjuvant Study”
- Norman Wolmark · Nsabp Foundation, Inc.$230,572,398
- Lawrence Corey · Fred Hutchinson Cancer Center$227,004,335
- David Heimbrook · Leidos Biomedical Research, Inc.$152,219,190
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
- Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$89,007,870
Research focus
Adjuvant StudyAlphavirusAnimalsAntibodiesAntibody FormationAntigensBaculovirusesBaseChildhoodChinese PeopleClinical TrialsCombined VaccinesComparativeCytokineDocumentationDoseDrug FormulationsEnzyme-Linked Immunosorbent AssayEnzyme Linked Immunospot AssayEpitopesFundingGaggingGeneric DrugsAdjuvant